Lynparza 150 MG tablet UU 60S
Ended Awarded
- Contract number
- SPE2DB25FWQ52
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,499
Award facts
- Contract value 100% obligated
- $10,499.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of LYNPARZA 150 mg tablets (60-count units) valued at $10,499.34. This competitively awarded, firm fixed-price delivery order is set to be completed by August 19, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement and has extensive experience fulfilling pharmaceutical supply requirements for military and veteran healthcare systems through the DLA's Medical Supply Chain.
This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The IDC enables the contractor to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. This delivery order for LYNPARZA—an oncology medication—exemplifies the contractor's role in providing specialized pharmaceutical products to Defense Health Agency and other federal healthcare systems through a flexible contract framework.
Quick answers
Who was awarded contract SPE2DB25FWQ52?
SPE2DB25FWQ52 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 29, 2025.
How much is contract SPE2DB25FWQ52 worth?
The government has obligated $10,499 on SPE2DB25FWQ52.
Is contract SPE2DB25FWQ52 an order under another contract?
Yes. SPE2DB25FWQ52 is a delivery order under SPE2DB22D3501, an indefinite delivery contract.
Was contract SPE2DB25FWQ52 competed?
The extent of competition for SPE2DB25FWQ52 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award